UroAlert - GU Oncology Daily

July 21, 2026

Videos

Peer-to-Peer Clinical Conversations

Radiopharmaceuticals in Prostate Cancer Part 2: Mechanisms and Clinical Considerations - Philip Kantoff, Ken Herrmann & Neil Bander

Phil Kantoff

Phillip Koo moderates a panel with Ken Herrmann, Philip Kantoff, and Neil Bander on alpha-emitting radiopharmaceuticals in prostate cancer.

Design and Safety of a Patient-Centric Expanded Access Program with Cretostimogene Grenadenorepvec - Sarah Psutka

Sarah Psutka

Sarah Psutka discusses cretostimogene grenadenorepvec expanded access program with Ashish Kamat.

Beyond the Abstracts

Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration - Beyond the Abstract

Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer - Beyond the Abstract

Conference Coverage

ASCO 2026: Initial Results from EXCEED, a Phase 1 Study of LY4101174, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants with Advanced or Metastatic Urothelial Carcinoma

ASCO 2026: PEAK-1: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients with Advanced Clear Cell RCC

AUA 2026: A Phase 1/2 Study of Intravesical MK-3120 in Participants with Bacillus Calmette-Guérin (BCG)-Naive or BCG-Exposed High-Risk Non–muscle Invasive Bladder Cancer

AUA 2026: Interim Analysis of Light-Activated TLD-1433 in a Phase II Clinical Study of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ

EAU 2026: Adjuvant Pembrolizumab + Belzutifan for Clear Cell RCC: Primary and Exploratory Efficacy Outcomes from the Phase 3 LITESPARK-022 Study

Articles

Editor Selected Abstracts and Commentaries

Bladder Cancer

VI-RADS Score Performance in the Post-TURBT Setting: Exploring the Need for Modification.

Shaping the role of FDG PET in bladder cancer: current evidence and ongoing clinical trial.

Renal Cancer

Impact of robotic access and dedicated kidney surgery teams on nephron-sparing surgery for T1 renal masses: evidence from a Spanish multicenter registry.

Immune checkpoint profiling of B7-H proteins predicts survival and treatment response in metastatic clear cell renal cell carcinoma.

Patient-Reported Outcome Design and Analysis in Randomized Controlled Trials of Renal Cell Carcinoma: A Systematic Review.

Prostate Cancer

Structured robotic surgery training in Germany: a five-year evaluation of the German curriculum for robot-assisted radical prostatectomy.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Global research trends and hotspots in robotic-assisted prostate biopsy: a bibliometric analysis from 2008 to 2026.

CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer.

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis.

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer - Beyond the Abstract

SBRT plus Abiraterone Acetate and ADT versus Abiraterone Acetate and ADT in Oligometastatic Castrate-Resistant Prostate Cancer (ARTO): Long-Term, Unplanned Overall Survival Analysis of an Open-Label, Randomised, Phase 2 Trial - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC